Security record · archived quarter
ANRO
Alto Neuroscience, Inc. · Healthcare · Biotechnology
5Tracked holders
0Δ holders
2.33MShares held
$26.66MReported value
+2New positions
−2Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +17.8% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | +2 | 11.55M | $304.50M | +10 | −8 |
| Q1 2026 | 55 | +7 | 8.39M | $188.63M | +8 | −1 |
| Q4 2025 | 48 | +2 | 8.42M | $149.83M | +3 | −1 |
| Q3 2025 | 15 | +1 | 4.77M | $19.16M | +1 | — |
| Q2 2025 | 12 | 0 | 4.77M | $10.50M | +1 | −1 |
| Q1 2025 | 9 | +1 | 3.54M | $7.65M | +2 | −1 |
| Q4 2024 | 8 | +2 | 5.27M | $22.30M | +2 | — |
| Q3 2024 | 5 | 0 | 2.33M | $26.66M | +2 | −2 |
| Q2 2024 | 5 | — | 1.98M | $21.15M | — | — |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 977.69K | -6.9% | $11.18M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 808.50K | +25.2% | $9.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 808.50K | +25.2% | $9.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 469.99K | +148.7% | $5.38M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 469.99K | +148.7% | $5.38M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 60.64K | New | $693,676 | 0.0% | New | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 60.64K | New | $693,676 | 0.0% | New | 1 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 12.94K | New | $148,034 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Wellington Management | $693,676 | 0.0% |
| Wellington Management | $693,676 | 0.0% |
| Two Sigma Investments | $148,034 | 0.0% |
Exited
| Norges Bank | $819,624 | was 0.0% |
| Millennium Management | $179,998 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 108 holders, 26.83M shares, $592.78M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API